Literature DB >> 7583930

Levels of interleukin 6 and tumor necrosis factor in serum from humans vaccinated with live, attenuated Francisella tularensis.

T Krakauer1.   

Abstract

The levels of interleukin 6 (IL-6) and tumor necrosis factor alpha in serum did not change significantly during the course of immunization with the live vaccine strain of Francisella tularensis. Higher levels of circulating IL-6 were found in the sera of vaccinees with good antibody responses than in the sera from nonresponders. Preimmunization levels of IL-6 in serum were also higher in responders than in nonresponders.

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7583930      PMCID： PMC170185          DOI： 10.1128/cdli.2.4.487-488.1995

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN： 1071-412X


  10 in total

1.  In vivo modulation of the murine immune response to Francisella tularensis LVS by administration of anticytokine antibodies.

Authors:  D A Leiby; A H Fortier; R M Crawford; R D Schreiber; C A Nacy
Journal:  Infect Immun       Date:  1992-01       Impact factor: 3.441

2.  Interleukin 2 and gamma interferon production, interleukin 2 receptor expression, and DNA synthesis induced by tularemia antigen in vitro after natural infection or vaccination.

Authors:  R Karttunen; G Andersson; H P Ekre; K Juutinen; H M Surcel; H Syrjälä; E Herva
Journal:  J Clin Microbiol       Date:  1987-06       Impact factor: 5.948

3.  Agglutinins and antibodies to Francisella tularensis outer membrane antigens in the early diagnosis of disease during an outbreak of tularemia.

Authors:  L Bevanger; J A Maeland; A I Naess
Journal:  J Clin Microbiol       Date:  1988-03       Impact factor: 5.948

Review 4.  Nature of protective immunity to Francisella tularensis.

Authors:  A Tärnvik
Journal:  Rev Infect Dis       Date:  1989 May-Jun

5.  Immunization against tularemia: analysis of the effectiveness of live Francisella tularensis vaccine in prevention of laboratory-acquired tularemia.

Authors:  D S Burke
Journal:  J Infect Dis       Date:  1977-01       Impact factor: 5.226

6.  Francisella tularensis-induced in vitro gamma interferon, tumor necrosis factor alpha, and interleukin 2 responses appear within 2 weeks of tularemia vaccination in human beings.

Authors:  R Karttunen; H M Surcel; G Andersson; H P Ekre; E Herva
Journal:  J Clin Microbiol       Date:  1991-04       Impact factor: 5.948

7.  Cell-mediated and humoral immunity induced by a live Francisella tularensis vaccine.

Authors:  P Koskela; E Herva
Journal:  Infect Immun       Date:  1982-06       Impact factor: 3.441

8.  Costimulatory receptors for the superantigen staphylococcal enterotoxin B on human vascular endothelial cells and T cells.

Authors:  T Krakauer
Journal:  J Leukoc Biol       Date:  1994-10       Impact factor: 4.962

9.  Live vaccine strain of Francisella tularensis: infection and immunity in mice.

Authors:  A H Fortier; M V Slayter; R Ziemba; M S Meltzer; C A Nacy
Journal:  Infect Immun       Date:  1991-09       Impact factor: 3.441

10.  A sensitive, specific immunobioassay for quantitation of human interleukin 6.

Authors:  T Krakauer
Journal:  J Immunoassay       Date:  1993-12
  10 in total
  5 in total

1.  Levels of proinflammatory cytokines in plasma after pneumoccoccal immunization in human immunodeficiency virus type 1-infected patients.

Authors:  H Valdez; S Purvis; R Asaad; I Valerio; B E Sha; A L Landay; M M Lederman
Journal:  Clin Diagn Lab Immunol       Date:  1999-05

2.  Nutritional and Physical Activity Interventions to Improve Immunity.

Authors:  Glen Davison; Corinna Kehaya; Arwel Wyn Jones
Journal:  Am J Lifestyle Med       Date:  2014-11-25

3.  In Vivo Intradermal Delivery of Bacteria by Using Microneedle Arrays.

Authors:  Alison J Scott; Robert K Ernst; Courtney E Chandler; Erin M Harberts; Tim Laemmermann; Qin Zeng; Belita N Opene; Ronald N Germain; Christopher M Jewell
Journal:  Infect Immun       Date:  2018-08-22       Impact factor: 3.441

4.  Acute exercise enhancement of pneumococcal vaccination response: a randomised controlled trial of weaker and stronger immune response.

Authors:  Kate M Edwards; Meredith A Pung; Lianne M Tomfohr; Michael G Ziegler; John P Campbell; Mark T Drayson; Paul J Mills
Journal:  Vaccine       Date:  2012-08-22       Impact factor: 3.641

5.  Changes in TNF and IL-6 production after diphtheria toxoid vaccination: drug modulation of the cytokine levels.

Authors:  A L Pukhalsky; M S Bliacher; A V Danilina; E A Kalashnikova; T K Lopatina; I M Fedorova
Journal:  Mediators Inflamm       Date:  1996       Impact factor: 4.711
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.